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To understand the lack of protective immunity observed after infection with parainfluenza virus type 3 (PIV3), we tested the
effect of the virus on human monocytes and monocyte-derived immature dendritic cells (DCs). Expression of viral antigens
on the cell surfaces correlated with replication of the virus, which was marginal in monocytes but extremely efficient in DCs.
The virus increased monocyte survival at least in part through the production of granulocyte–macrophage colony-stimulating
factor but, in contrast, accelerated DC apoptosis. In addition, PIV3 infection failed to activate monocytes but induced
maturation of DCs with increased expression of CD54, HLA-DR, CD86, and CD83 and production of bioactive IL-12. However,
PIV3-infected DCs demonstrated low stimulatory properties in DC–T cell cocultures, a finding that could not be attributed to
the production of infectious virus or IL-10. These results demonstrate for the first time that PIV3 dramatically modifies the
survival and/or the function of antigen-presenting cells and might therefore prevent the development of efficient antiviral
immune responses. © 2001 Academic Press
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1INTRODUCTION
Parainfluenza virus type 3 (PIV3) is a major respiratory
tract pathogen responsible for bronchiolitis, pneumonia,
and croup (Reed et al., 1997). Initial infection occurs
during infancy and early childhood, with the peak inci-
dence of severe illness between 4 and 12 months of age.
Reinfection is a common event and may occur several
times, even in adolescents and adults (Marx et al., 1999;
elliver et al., 1982), although clinical manifestations
ecome progressively more restricted to the upper re-
piratory tract. The repeated occurrence of PIV3 infection
annot be explained by antigenic shift of the virus, which
s relatively stable (Chanock et al., 1961). Furthermore,
ersistence of PIV3 has been documented in various
ituations (Goswami et al., 1984; Muchmore et al., 1981).
onsequently, and in marked contrast with epidemic
atterns of other respiratory infections, PIV3 may be
ecovered almost continuously in the human population
Chanock et al., 1961; Glezen et al., 1971).
The ability to reinfect, within a short time interval, the
ame individual and to cause persistent infection sug-
ests that PIV3 fails to induce a state of long-lasting
mmunity. Although the respiratory disease and the
ength of virus shedding seem to be reduced in the
resence of high titers of neutralizing antibodies
Chanock et al., 1961), activation of T cell responses may
e essential in recovery, since the most severe infections
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82ccur in individuals with defects in cell-mediated immu-
ity (Dorman et al., 1999; Fishaut et al., 1980) or with
evere combined immunodeficiency disease (Taylor et
l., 1998).
Previous studies have demonstrated that PIV3 pro-
oundly impairs T cell functions in vitro. The virus infects
ctivated T lymphocytes and significantly decreases
heir proliferative capacity (Sieg et al., 1994). IL-10 pro-
uced by blood mononuclear cells maintains these in-
ected cells in a nonresponsive state. In addition, T cell
ytotoxicity is prevented by selective inhibition of gran-
yme B mRNAs (Sieg et al., 1995).
The development of antiviral T cell responses relies on
pecific interactions between naive T cells and profes-
ional antigen-presenting cells (APCs) such as dendritic
ells (DCs) and monocytes/macrophages. Although less
otent than DCs in stimulating naive T cells, monocytes
re involved in the restimulation of memory and effector
cells, which have less of a requirement for cosignals
nd accessory molecules (Diaz et al., 1997). In contrast,
Cs are crucial for the initiation of a primary response.
mmature DCs are located in most nonlymphoid tissues,
ncluding the respiratory mucosa, where they capture,
rocess, and carry foreign antigens (Ags) to the second-
ry lymphoid organs (Banchereau et al., 1998; Cella et al.,
997; Steinman et al., 1999). During their migration, DCs
are thought to undergo modulation of both phenotype
and function, a process referred to as DC maturation.
They express high levels of costimulatory molecules
(such as CD40, CD54, CD58, CD86, and MHC class I/II),
become CD83-positive, and lose their ability to capture
Ags. The resulting mature DCs activate naive T cells and
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83PARAINFLUENZA VIRUS TYPE 3 INFECTION OF HUMAN ANTIGEN-PRESENTING CELLSstimulate primary T cell responses. In addition, they
produce cytokines such as IL-12 that are critically in-
volved in the generation of Th1 responses and the gen-
eration of cellular immunity (Trinchieri, 1998). However, a
variety of pathogens have been shown to be able to
infect professional APCs and either to induce or to inhibit
their stimulatory properties (Cella et al., 1999; En-
gelmayer et al., 1999; Klagge and Schneider-Schaulies,
1999; Salio et al., 1999).
Since induction of T cell immunity via activation of
professional APCs may be central in the control of PIV3
infection, the aim of this study was to examine the effect
of PIV3 on human monocytes and DCs. Our results dem-
onstrate that PIV3 differentially affects these cells. While
it increases the survival of monocytes and replicates
poorly in these cells, it’s replication is massive and highly
toxic for DCs. Furthermore, although maturation of DCs
is induced with the production of IL-12, the infected cells
demonstrate low stimulatory properties.
RESULTS
Replication of PIV3 in DCs and monocytes
Expression of viral antigens on the surfaces of mono-
cytes and DCs was determined by FACS analysis. These
antigens were expressed at very low levels on the whole
monocyte population after infection at a m.o.i. of 10 (Figs.
1A and 1B). In contrast, they were detected from day 1
(16 h) on DCs and increased in a time and dose-depen-
dent manner to reach a maximum at day 2 of a m.o.i. of
10, at which stage most of the cells were positive (Figs.
1C and 1D). As expected, PIV3 antigens were undetect-
able on mock-infected monocytes and DCs or on these
cells previously incubated with UV-inactivated PIV3 (not
shown).
The infectious PIV3 yield was determined in the su-
pernatants of these cells. As indicated in Table 1, PIV3
was always detected at levels close to the limit of de-
tection of the assay in cultures of infected monocytes
(from 0.70 to 1.33 log10 TCID50/ml), even when infection
as performed after previous stimulation of these mono-
ytes with LPS or CD40 ligand (not shown), attesting to
he poor replication rate of PIV3 in these cells. In con-
rast, PIV3 was present at high levels from 16 h onward
n DC cultures and with more than 5.20 log10 TCID50/ml by
day 1, at all m.o.i.s tested. No virus was detected in
control cultures or in cultures after infection with UV-
inactivated virus (,0.45 TCID50/ml).
Thus, in agreement with cell surface expression of
viral antigens, PIV3 replicates marginally in monocytes
but very efficiently in DCs.
PIV3 increases monocyte survival and accelerates
DC apoptosisThe effect of PIV3 infection on monocytes and DCs
was investigated by determination of cell survival.Monocytes progressively died in all cultures from day
1 onward by an apoptotic-related mechanism (Mangan
and Wahl, 1991). At day 3, the proportion of live cells in
mock-infected cultures was lower than 40% (Fig. 2A).
As expected (Mangan and Wahl, 1991), cell survival
increased in the presence of exogenous granulocyte–
macrophage colony-stimulating factor (GM-CSF) (Fig.
2B). Surprisingly, infection with PIV3 decreased mono-
cyte apoptosis in a dose-dependent manner with an
effect significant at a m.o.i. of 1 and maximal at a m.o.i.
of 5 or 10: more than 75% of monocytes were still alive
72 h after infection with PIV3 at a m.o.i. of 10 (Fig. 2C).
Furthermore, this effect was also induced after incu-
bation of monocytes with UV-inactivated virus (not
shown), indicating that virus–cell interactions were
involved but that the increased monocyte survival was
independent of viral replication. In contrast to mono-
cytes, infection of immature DCs with PIV3 resulted in
a significant increase in cell apoptosis (Figs. 2E and
2F), except when PIV3 had been previously UV-inacti-
vated (not shown). More than 60% of DCs were dead or
undergoing apoptosis at day 3 after infection with PIV3
at a m.o.i. of 5 (Fig. 2E) and almost no cells survived at
a m.o.i. of 10 (Fig. 2F).
FIG. 1. Expression of PIV3 antigens on monocytes and DCs. Mono-
cytes and DCs were mock-infected or exposed to PIV3. Expression of
viral antigens was determined by FACS analysis 1 and 2 days after
infection of monocytes (A and B, respectively) or DCs (C and D,
respectively) with PIV3 of a m.o.i. of 10. Data (MFI) show infected versus
uninfected cells after staining with anti-PIV3 antiserum. None of these
cells was stained with the control antiserum (not shown). Results are
representative of one of five separate experiments.Thus, infectious PIV3 induced opposite effects on
monocytes and DC programmed cell death, favoring
Mxpress
84 PLOTNICKY-GILQUIN ET AL.monocyte survival and accelerating immature DC apo-
ptosis.
PIV3 increases monocyte survival by induction of
GM-CSF
Apoptosis of blood monocytes can be prevented by a
number of cytokines, including GM-CSF (Mangan and
Wahl, 1991). Indeed, GM-CSF mRNA was significantly
T
PIV3 Replication in Cul
None 1
onocytes
Day 1 ,0.45 #0.70 6 0
Day 2 ,0.45 ,0.45
Day 3 ,0.45 ,0.45
DCs
16 h ,0.45 #2.95 6 0.35
Day 1 ,0.45 .5.20
Day 2 ,0.45 .5.20
Day 3 ,0.45 .5.20
Note. Monocytes and immature DCs were incubated or not with live
after 1, 2, or 3 days of culture and PIV3 titers calculated. Results are e
experiments. nd, not done.
FIG. 2. Dual effects of PIV3 on apoptosis of monocytes and DCs. M
viability and apoptosis were evaluated at 72 h in cultures containing un
(B), monocytes infected with PIV3 at a m.o.i. of 10 (C), uninfected DCs (D), a
representative of one of six separate experiments.induced in PIV3-infected monocytes at a m.o.i. of 5 (Fig.
3A, lane 3) as well as in monocytes previously incubated
with UV-inactivated virus (Fig. 3, lane 4). To determine
whether GM-CSF was also translated in these cells and
could play a role in the increased survival of infected
monocytes, an anti-GM-CSF neutralizing Ab was added
into the PIV3-infected cultures at day 0. As represented
in Fig. 3B, infection of monocytes at a m.o.i. of 5 signifi-
f DCs and Monocytes
m.o.i.
5 10 10 (inactivated)
0.76 6 0.37 #1.33 6 1.20 ,0.45
#0.9 6 0.37 ,0.45 ,0.45
0.86 6 0.52 #0.70 6 0 ,0.45
3.95 6 0.70 nd ,0.45
.5.20 .5.20 ,0.45
.5.20 .5.20 ,0.45
.5.20 .5.20 ,0.45
inactivated PIV3 at a m.o.i. of 1, 5, or 10. Supernatants were collected
ed as log10 TCID50 of PIV3/ml and are representative of four separate
tes and immature DCs were mock-infected or exposed to PIV3. Cell
monocytes alone (A), monocytes cultured in the presence of GM-CSFABLE 1
tures o
#
#
#
or UV-onocy
infectednd DCs infected at a m.o.i. of 5 (E) and at a m.o.i. of 10 (F). Data are
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85PARAINFLUENZA VIRUS TYPE 3 INFECTION OF HUMAN ANTIGEN-PRESENTING CELLScantly increased the number of viable cells compared to
that in mock-infected monocytes. The anti-GM-CSF Ab
reduced the number of viable monocytes by an average
FIG. 3. The role of GM-CSF in the increased survival of PIV3-infected
monocytes. Monocytes were mock-infected, exposed to infectious or
UV-inactivated PIV3, and cultured for 2 days. (A) PCR amplification of
b-actin and GM-CSF mRNAs in monocytes cultured alone (lane 1), in
the presence of GM-CSF (lane 2), or after incubation with infectious
(lane 3) or inactivated (inac) PIV3 at a m.o.i. of 5 (lane 4). (B) The % of
viable cells 1, 2, or 3 days after culture of monocytes previously infected
at a m.o.i. of 5 and cultured in the presence of 20 mg/ml of anti-GM-CSF
or control Ab in one representative experiment of three.
T
PIV3 Induces
Stimulusa CD54b DRb
None 82 25
PIV3, m.o.i. 5 133 102
PIV3, m.o.i. 5 (inactivated) 180 118
TNF-a (20 ng/ml) 180 118
LPS (100 ng/ml) — —
Note. Data are representative of one of three separate experiments
a Immature DCs were exposed to infectious or UV-inactivated PIV3 (
were determined by FACS analysis as indicated under Materials and
b Results are expressed in MFI values after substraction of the valu
c Results show the percentages and the MFI values of the positive cells.
d Results show the level of IL-12 in ng/ml obtained in culture of DCs 2 dayof 50% from day 1 to day 3, with similar effects at 10 or 20
mg/ml. An isotype-matched control Ab had no significant
effect. Thus, PIV3 increases the survival of monocytes at
least in part through the induction of GM-CSF.
PIV3 induces DC maturation but does not affect
monocyte activation
Since virus infection may induce maturation of APCs
(Cella et al., 1999; Iwasaki and Kelsall, 1999), we inves-
tigated the ability of PIV3 to activate monocytes and DCs.
As represented in Table 2, increased expression of
CD54, HLA-DR, and CD86 as well as induction of CD83
was evident on DCs after previous infection with PIV3, as
was observed when DCs were cultured with TNF-a. In
ddition, these cells appeared veiled under light micros-
opy (not shown). These criteria correspond to DC mat-
ration. Interestingly, these phenomenons were also ob-
erved with UV-inactivated PIV3, indicating that viral rep-
ication was not required but that cell interactions with
irus particles were sufficient. Furthermore, a significant
evel of IL-12 was detected both in cultures of PIV3-
nfected DCs and in DCs after incubation with the UV-
nactivated virus. In contrast, infectious and UV-inacti-
ated PIV3 consistently failed to induce activation of
onocytes, as indicated by low expression of CD54,
D80, CD86, CD58, and HLA-DR on these cells at all
oses and days tested (not shown). Thus, although in-
ubation with PIV3 does not induce monocyte activation,
t is very effective at inducing a maturation-like pheno-
ype in DCs.
IV3-infected DCs display impaired stimulatory
roperties
The stimulatory properties of PIV3-infected DCs were
valuated in DC–T cell cocultures. Immature DCs were
ncubated with infectious or inactivated PIV3 and cul-
ured for 2 days. Negative and positive control DCs for
ation of DCs
CD86c CD83c
IL-12d (ng/ml)MFI % MFI
36 15 8 0.5
361 100 46 4.5
270 43 27 2.2
213 100 75 —
— — 5.6
f 5), to TNF-a, or to LPS. Three days later, the phenotypes of the DCs
s.
ined with control mAbs.ABLE 2
Matur
%
15
100
100
100
—
.
m.o.i. o
Method
es obtas after stimulation.
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86 PLOTNICKY-GILQUIN ET AL.maturation were obtained with immature DCs cultured in
medium alone and DCs cultured in the presence of
TNF-a, respectively. In contrast to DCs cultured with
TNF-a, PIV3-infected DCs failed to stimulate allogeneic T
cell proliferation. As shown in Fig. 4, thymidine uptake at
day 3 was similar in cultures containing mock-infected or
PIV3-infected DCs (at a m.o.i. of 5 or 10). A similar effect
was obtained at day 5 (not shown) and with DCs previ-
ously incubated with the UV-inactivated virus (Fig. 4). T
cell proliferation was similarly inhibited after fixation of
DCs with paraformaldehyde (not shown). Thus, despite
up-regulation of costimulatory molecules, PIV3-infected
DCs are poor stimulators of allogeneic T cell prolifera-
tion.
DISCUSSION
PIV3 causes repeated pulmonary infections thought to
be due to the induction of ineffective immune responses.
In this study, we demonstrate that PIV3 profoundly mod-
ifies the survival and/or the function of APCs and may
thus hinder the establishment of a state of long-lasting
immunity.
Immature DCs are highly susceptible to PIV3 infection,
which leads to massive replication of the virus and in-
duces cell apoptosis after a few hours. This indicates
FIG. 4. PIV3-infected DCs display poor stimulatory properties. Imma-
ture DCs were exposed to infectious or UV-inactivated (PIV3 inac) PIV3
at a m.o.i. of 1 or 5 and cultured for 2 days. Negative and positive
control cells for maturation were obtained with immature DCs cultured
in medium alone and immature DCs cultured in the presence of TNF-a,
respectively. All DCs were then UV-irradiated and cultured for 3 days
with allogenic T cells at a DC:T cell ratio of 1:4 as described under
Materials and Methods. Results represent the mean cpm 6 SD calcu-
lated with quadruplicate values from one representative experiment of
five.that DCs, which are present in the airway epithelium and
which can be rapidly recruited at this site after exposure
i
1to various pathogens (Iwasaki and Kelsall, 1999; McWil-
liam et al., 1996), are a major target of PIV3. Furthermore,
these cells probably contribute to active dissemination of
the virus. DCs have been shown to be susceptible to
infection by other viruses such as HIV and measles.
These viruses replicate at a relatively low level in these
cells, except upon activation, membrane interactions
with molecules such as CD40, and interaction with T
lymphocytes (Granelli-Piperno et al., 1999; Fugier-Vivier
et al., 1997). Therefore, the majority of viral replication in
vivo probably occurs during cellular interactions. Indeed,
DCs are thought to serve as a reservoir for these viruses
and a vehicle for transmitting infection to lymphoid cells
in the draining lymph nodes. In contrast, PIV3 replication
in DCs is spontaneously efficient. It starts after a few
hours and results in the rapid elimination of these cells.
Unlike DCs infected with HIV or measles, it is likely that
most PIV3-infected DCs die within the pulmonary tissues
where they get infected and that only small numbers of
DCs are able to reach the draining lymph nodes. Inter-
estingly, cell susceptibility to PIV3 infection seems to
correlate with the differentiation rather than the activa-
tion state of the cells, since we found that the virus
replicates poorly in resting and activated monocytes, but
replicates very efficiently after a 4-day culture of these
monocytes with GM-CSF (i.e., in macrophages) (personal
observation) or with IL-4 and GM-CSF (i.e., in immature
DCs). These results suggest that different cell receptor(s)
for the virus are expressed on monocytes, macrophages,
and DCs and/or that the consequences of viral interac-
tions with these receptor(s) differ with the state of cell
differentiation.
Previously, Cella et al. (1999) demonstrated that DC
ctivation by viruses such as influenza results in the
nduction of type I IFN, which triggers cellular resistance
o cytopathic effects via upregulation of MxA. This in-
reased resistance allows infected DCs to present the
orresponding antigens and to induce protective im-
une responses. Accordingly, Bender et al. (1998)
howed that influenza virus infection of DCs is nontoxic,
s viral expression on these cells is sustained for more
han 2 days with retention of viability. In our experiments,
strong induction of IFN-a in PIV3-infected DC could
also be demonstrated by RT–PCR (personal observa-
tion). In addition, PIV3 replication was shown to be sig-
nificantly reduced by IFN-a and MxA (Zhao et al., 1996).
owever, the rapid destruction of DCs and intense pro-
uction of infectious virus after infection indicates that
ranscription of IFN-a fails to induce protective levels of
xA and/or that the virus neutralizes the activity of either
FN-a or MxA.
As shown in vitro, although most DCs are rapidly
liminated by apoptosis, the surviving DCs may undergo
apid maturation and, in contrast to HIV- or measles-
nfected DCs (Chehimi et al., 1994; Fugier-Vivier et al.,
997), produce spontaneously increased levels of IL-12.
k
i
W
c
i
t
I
T
I
a
e
s
D
T
p
n
b
f
e
v
t
w
s
u
a
U
v
l
s
t
t
p
i
a
t
F
b
m
(
a
c
c
n
f
a
1
c
G
i
r
e
T
a
w
f
c
c
u
m
p
t
(
t
r
g
s
t
1
d
(
f
c
b
t
l
M
s
m
f
1
I
2
G
87PARAINFLUENZA VIRUS TYPE 3 INFECTION OF HUMAN ANTIGEN-PRESENTING CELLSHowever, despite up-regulation of costimulatory mole-
cules, PIV3-infected DCs display only poor stimulatory
properties that fail to induce efficient T cell proliferation.
Previous work has demonstrated that incubation of
peripheral blood mononuclear cells (PBMC) with PIV3
leads to the production of IL-10 (Sieg et al., 1996). IL-10 is
nown to play an important immunoregulatory role in
nfection with viruses such as EBV, HIV, and CMV (De
aal Malefyt et al., 1991; Redpath et al., 1999) by de-
reasing antigen presentation and IL-2 secretion, reduc-
ng T cell blastogenesis and preventing T cell prolifera-
ion (De Waal Malefyt et al., 1991; Taga and Tosato, 1992).
n our study, the poor stimulatory effect of infected DCs in
cell cocultures was not attributable to the production of
L-10, which was indeed undetectable in infected DCs
nd monocyte cultures (data not shown). In addition, this
ffect was not due to other soluble factors nor to newly
ynthesized virions able to infect the T cells because all
Cs were washed and UV-irradiated before inclusion in
cell cultures, and similar effects were observed with
araformaldehyde-fixed cells.
Such a discrepancy between the maturation-like phe-
otype and the poor stimulatory ability of these DCs has
een previously described for tumor-infiltrating DCs and
or DCs previously infected with measles virus (Ki-
rtscher et al., 2000; Grosjean et al., 1997). For measles
irus-infected cells, this phenomenon was attributed to
he presence of undefined surface molecules because it
as also observed with fixed cells.
A direct role for viral-encoded proteins is conceivable
ince purified influenza glycoproteins can directly mod-
late the activity of immune cells (Arora et al., 1984; Arora
nd Houde, 1992). In addition, we demonstrated that
V-inactivated PIV3 has the capacity, like the infectious
irus, to completely prevent T cell proliferation in mixed
ymphocyte cultures and in cultures with mitogen (per-
onal observation). This indicates that the blockade of
he T cell response does not require T cell infection but
hat it can result directly from interactions of inert viral
articles on the cell surface.
Monocytes/macrophages are known to be involved in
mmune regulation and are capable of both activating
nd suppressing lymphocyte function (Wing and Reming-
on, 1977; Unahue and Allen, 1987; Chouaib and
radelizi, 1982). Previous studies have demonstrated that
ovine PIV3 significantly impairs the ability of alveolar
acrophages to stimulate other immune effector cells
Adair et al., 1992; Basaraba et al., 1993). These results
re in accordance with ours showing that expression of
ostimulatory molecules is not up-regulated on mono-
ytes infected with the human virus. Thus, these cells do
ot express surface molecules required for efficient ef-
ector/memory T lymphocyte restimulation.
Interestingly, in contrast to other paramyxoviruses thatre lytic to monocytes (Tropea et al., 1995; Esolen et al.,
995), PIV3 significantly increases the survival of theseells by the induction of an autocrine loop involving
M-CSF. This phenomenon is also obtained with the
nactivated virus, confirming the observation that viral
eplication is not necessary to induce the remarkable
ffects of PIV3 on monocyte survival, DC maturation, and
cell proliferation, but that virus/cell surface interactions
re sufficient.
The increased survival of monocytes following contact
ith the infectious virus could favor persistence of in-
ected cells in vivo. In addition, as shown in cultures, it is
onceivable that PIV3 replication also occurs sporadi-
ally in vivo and may be stimulated under the influence of
nknown biological factors. Under these circumstances,
onocytes could be responsible for PIV3 latency after
rimary infection and account for the resurgent infec-
ions that have been described in some individuals
Chanock et al., 1961; Muchmore et al., 1981).
Thus, we have demonstrated that PIV3 might prevent
he development of efficient and long-lasting immune
esponses by modifying the critical steps required for the
eneration and the reactivation of T cell immune re-
ponses, while blood monocytes might constitute a po-
ential in vivo reservoir for the virus.
MATERIALS AND METHODS
. Monocyte isolation and DC generation
PBMC were isolated from healthy volunteers by stan-
ard density gradient centrifugation on Ficoll–Hypaque
Pharmacia, Uppsalla, Sweden). Monocytes were puri-
ied from PBMC by positive selection using a magnetic
ell separator (MACS; Miltenyi Biotex, Bergisch Glad-
ach, Germany) according to the manufacturer’s instruc-
ions. Purity, assessed by FACS analysis using a FITC-
abeled anti-CD13 mAb (Cymbys, Hants, UK), was .95%.
onocytes were cultured in culture medium (CM) con-
isting of RPMI 1640 supplemented with 10% FCS, 2 mM
L-glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin, 10
M HEPES, and 0.1 mM nonessential amino acids (all
rom Life Technologies, Cergy Pontoise, France) at 5 3
06 cells/5 ml/well in 6-well tissue culture plates (Costar,
Cambridge, MA) with 20 ng/ml IL-4 and 20 ng/ml GM-
CSF (R&D Systems, Abingdon, UK). On day 6, cells were
analyzed by FACS, as described above; only homoge-
neous immature DC populations characterized by high
levels of CD1a and an absence of CD83 expression were
used. Monocytes and DCs were then cultured at 106
cells/1 ml/well in 24-well flat-bottom tissue culture plates
(Costar) in CM and in cytokine-containing CM. Measure-
ment of virus or cytokine production was performed in
the supernatant of cultures set up with 2 3 106 cells/ml.
n some experiments, monocytes were stimulated with
0 ng/ml GM-CSF or cultured in the presence of anti-
M-CSF or control Abs (R&D Systems) at 10 or 20 mg/ml.In other experiments, monocytes and DCs were acti-
vated with 10 ng/ml of LPS (from Escherichia coli isotype
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88 PLOTNICKY-GILQUIN ET AL.0111:B4; Sigma Chemical Co., St. Louis, MO); maturation
of DCs was induced by incubation with 20 ng/ml TNF-a
(R&D Systems).
2. Virus preparation and infection
PIV3 (American Type Culture Collection (ATCC, Rock-
ville, MD, VR-93) was grown and propagated in Vero cells
(African green monkey kidney) in medium (DMEM, 2 mM
L-glutamine, 1 mg/ml gentamicin, 2.5% NaHCO2, 5% SVF,
Life Technologies) and purified on a sucrose gradient.
Inactivated PIV3 was obtained after UV irradiation for 45
min at 1 302.8 mW/cm2. Monocytes and DCs were in-
ected for 2 h at 37°C with PIV3, inactivated PIV3, or CM
t a m.o.i. from 1 to 10. Cells were washed extensively to
liminate the remaining virus and cultured at 37°C in
M. Virus production in cell-free supernatant was as-
essed by titration on Vero cell cultures, with titers being
alculated according to the Ka¨rber method (Dougherty,
964). Data are expressed as log10 tissue culture infec-
ious dose50% (TCID50)/ml.
. Flow cytometric measurement of surface Ag
xpression
FACS analysis was performed using a FACSvantage
ytofluorometer (Becton Dickinson, Erembodegem, Bel-
ium) with the following mAbs: FITC-labeled anti-CD1a
Immunoquality Products, Groningen, The Netherlands),
nti-CD80 and anti-CD86 (both from Pharmingen, San
iego, CA), and anti-CD54 and anti-HLA-DR (both from
ecton Dickinson). The binding of the anti-CD83 mAb
Immunotech, Marseille, France) was revealed by FITC-
abeled anti-mouse IgG Ab (Silenus, Hauworth, Austra-
ia). Expression of viral antigens on the cell surface was
etermined by incubation with polyclonal immune sera
1/200) obtained from BALB/c mice (purchased from IFFA
REDO, l’Arbresle, France) immunized by 3 ip injections
ither with 100 ml of purified PIV3 with complete Freund
adjuvant (50% v/v, Sigma) or, for the control mouse anti-
serum, with 20 mg of P40, which is the outer membrane
protein A (OMPA) of Klebsiella pneumoniae (Rauly et al.,
1999). FITC-labeled anti-mouse IgG Ab was used as a
secondary reagent. Control isotype mAbs were from
Dako (Glostrup, Denmark). Cells were analyzed using
Cellquest software after removing debris and staining
dead cells with propidium iodide (PI). Results are ex-
pressed in mean fluorescence intensity (MFI) values, as
the percentage of positive cells after subtraction of the
MFI, or the percentage obtained with the control mAb.
4. Determination of cell viability and apoptosis
Enumeration of viable cells was performed using the
trypan blue dye exclusion method. Cell apoptosis was
determined using the FITC-labeled annexin V kit (Immu-
notech) according to the manufacturer’s recommenda-
tions. Briefly, cell samples dispensed in a V-bottom 96-well plate were centrifuged and resuspended in 200 ml of
inding buffer in the presence of 3 ml of FITC–annexin V
nd 3 ml of PI. After a 10-min incubation on ice, cell
samples were analyzed by flow cytometry. Annexin Vneg-
PIneg cells represent living cells, annexin Vpos-PIneg cells
epresent early apoptotic cells, and annexin Vpos-PIpos
cells define late apoptotic and secondary necrotic cells.
5. Quantification of bioactive IL-10 and IL-12
DCs were incubated for 48 h with various stimuli, as
described above, and IL-10 and the biologically active
IL-12 p40/p35 heterodimer (IL-12 p75) were measured in
cell-free culture supernatants. IL-10 was quantified by
ELISA using a commercial kit (R&D Systems) according
to the manufacturer’s recommendations (sensitivity of 0.5
pg/ml). The concentration of the biologically active IL-12
p40/p35 heterodimer (IL-12 p75) was determined in cell-
free culture supernatants by flow cytometry, using the
Quantiflow IL-12 Immunoassay kit (Bioergonomics, St.
Paul, MN) (sensitivity, 5 pg/ml). Briefly, 100 ml of culture
supernatants was dispensed in a V-bottom 96-well plate.
Two microliters of capture beads (anti-IL-12 antibody-
coated beads) was added per well and the plate was
incubated for 2 h at RT with orbital agitation. In parallel,
a standard curve was set up by adding 100 ml of IL-12
standards into wells. Beads were then washed three
times by adding 150 ml of 13 the IFA buffer provided with
the kit. Plates were decanted and 2 ml of PE-conjugated
IL-12 reporter antibody was added per well. After 1 h of
incubation at RT with orbital agitation, beads were
washed three times with IFA buffer, transferred into FACS
tubes, and analyzed by flow cytometry. The fluorescent
signal of the beads was collected in log scale and the
settings of the PE channel photomultiplier were adjusted
by running a blank bead provided in the kit. The mean
channel fluorescent signal of PE was recorded. A stan-
dard curve was built by plotting mean channel fluores-
cence versus IL-12 concentration, for IL-12 standards.
The concentration of IL-12 in experimental samples was
determined by comparing the mean channel fluores-
cence obtained with the standard curve. The IL-12 con-
centrations of samples are given in pg/ml.
6. Analysis of viral RNA and mRNA expression by
PCR
Briefly, cells were resuspended in 1 ml TRIzol reagent
(Life Technologies). After extraction with chloroform, total
RNA was precipitated by isopropyl alcohol. First-strand
cDNA was synthesized from 2 mg of total RNA by reverse
transcription using an oligo(dT) primer and reverse tran-
scriptase (Promega, Madison, WI). PCR amplification
was performed with an amount of cDNA corresponding
to 25 ng of starting total RNA (2 min at 94°C followed by
30 cycles (30 s at 94°C, 1 min at 60°C, and 1 min at 72°C)
and then followed by a final extension of 4 min at 72°C).
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59-ATGTGGCTGCAGAGCCTGCTGCTC-39 and 59-TCACT-
CCTGGACTGGCTCCCAGCAG-39 for GM-CSF and 59-
CATGGATGATGATATCGCCG-39 and 59-GCTGGAAGGTG-
GACAGCGAG-39 for b-actin. The PCR products were
analyzed on a 1% agarose gel by electrophoresis in the
presence of ethidium bromide.
7. Primary allogenic mixed lymphocyte reaction
DCs were washed and incubated with culture me-
dium, PIV3, or inactivated PIV3 at a m.o.i. of 5 or 10. After
washing, these cells were recultured at 2 3 106 cells/2
ml/well in 6-well culture plates in cytokine-containing
CM. Control cells for maturation were either unstimu-
lated or stimulated with 20 ng/ml TNF-a. On day 2 of the
culture, DCs were washed twice in CM, UV-irradiated
(0.25 J/cm2), and cultured in quadruplicate wells at 5 3
04 cells/200 ml/well in 96-well flat-bottom culture plates
ith 2 3 105 allogenic T cells. T cells were purified from
BMCs of healthy volunteers by rosetting with sheep red
lood cells. The purity of T cells assessed by FACS
nalysis using a FITC-labeled anti-CD3 mAb (Immuno-
ech) was .95%. After 3 or 5 days, cells were pulsed
uring the last 16 h with [3H]thymidine (0.25 mCi/well)
Amersham, Amersham, UK) and harvested, and thymi-
ine incorporation was counted using a Packard
900CA-Tricarb b-counter (Packard Instrument, Meriden,
CT). Results are expressed in cpm (means 6 SD) of
quadruplicate values.
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